Evidence map›Paper›PMID 41812080›Full record

ArticleJMIR AI2026

Enhancing COVID-19 Screening Models With Epidemiological and Mobility Features: Machine-Learning Model Study.

Hyunwoo Choo, Dohyung Lee, Soo-Yong Shin, Jiwoo Lee, Duhun Lee, Eonji Kim, Namsoo Oh, Christina Kim, Myeongchan Kim, Hyo Jung Kim

Abstract read
In one paragraph

Article in JMIR AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hyunwoo ChooDepartment of Digital Health, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0003-2981-0958
Dohyung LeeMobile Doctor Co., Ltd, Seoul, Republic of Korea.
Soo-Yong ShinDepartment of Digital Health, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-2410-6120
Jiwoo LeeMobile Doctor Co., Ltd, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0009-5801-306X
Duhun LeeMobile Doctor Co., Ltd, Seoul, Republic of Korea.
Eonji KimMobile Doctor Co., Ltd, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0001-3386-9226
Namsoo OhMobile Doctor Co., Ltd, Seoul, Republic of Korea.
Christina KimMobile Doctor Co., Ltd, Seoul, Republic of Korea.
Myeongchan Kim *Mobile Doctor Co., Ltd, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0003-3940-9850
Hyo Jung Kim *Department of Biomedical Software Engineering, The Catholic University of Korea, 43 Jibong-ro, Wonmi-gu, Bucheon-si, Gyeonggi-do, 14662, Republic of Korea, +82-10-3093-1790.ORCID http://orcid.org/0000-0001-9555-0926

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Despite the significant post-COVID-19 pandemic surge in research using symptom data and machine learning (ML) for patient screening, data on patient trajectories and epidemiological conditions, although crucial, have remained underused. Objective: This study aimed to enhance the performance of ML models for COVID-19 screening by incorporating mobility and epidemic information in addition to patient symptom data. Methods: Data, including daily self-reported symptoms, location information, and test results, were collected from 48,798 individuals using a smartphone app. These data were then combined with Our World in Data and national government epidemic information to train 5 ML-based screening models to classify patient infection status. The models were logistic regression, extreme gradient boosting, light gradient boosting machine, tabular data network, and Google AutoML. Results: The addition of mobility and epidemic data significantly improved the performance of all 5 models. The highest area under the receiver operating characteristic curve score increased from 0.8712 without mobility and epidemic data to 0.9104 with mobility and epidemic data. This highlights the considerable impact of external information on enhancing the performance of ML models. Conclusions: This study demonstrated the potential of using mobility and epidemic data, such as location information and epidemic data, in combination with patient symptom data to improve the accuracy of ML models for diagnosing COVID-19. Considering additional contextual information can enhance the ability to screen for COVID-19.

Indexed as

COVID-19deep learningepidemiologymachine learningmass screeningmobility data

Identifiers

PMID41812080
PMCPMC12978548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.